NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80 | +1.3% | 134,685 | -1.7% | 0.00% | – |
| Q2 2023 | $79 | -17.7% | 136,957 | -0.1% | 0.00% | – |
| Q1 2023 | $96 | -67.9% | 137,157 | +3.7% | 0.00% | -100.0% |
| Q4 2022 | $299 | -99.8% | 132,232 | +1184.4% | 0.00% | +100.0% |
| Q2 2021 | $177,000 | -14.1% | 10,295 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $206,000 | +12.6% | 10,320 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $183,000 | -7.1% | 10,760 | -9.3% | 0.00% | 0.0% |
| Q3 2020 | $197,000 | -28.4% | 11,860 | +0.1% | 0.00% | -50.0% |
| Q2 2020 | $275,000 | +21.1% | 11,853 | -7.0% | 0.00% | 0.0% |
| Q1 2020 | $227,000 | -20.9% | 12,745 | -4.2% | 0.00% | 0.0% |
| Q4 2019 | $287,000 | +7.5% | 13,306 | -9.1% | 0.00% | 0.0% |
| Q3 2019 | $267,000 | -48.4% | 14,645 | +0.9% | 0.00% | -60.0% |
| Q2 2019 | $517,000 | +15.7% | 14,520 | +9.2% | 0.01% | +25.0% |
| Q1 2019 | $447,000 | +28.8% | 13,301 | +26.1% | 0.00% | 0.0% |
| Q4 2018 | $347,000 | -52.1% | 10,546 | -11.2% | 0.00% | -42.9% |
| Q3 2018 | $724,000 | +209.4% | 11,876 | +148.2% | 0.01% | +250.0% |
| Q2 2018 | $234,000 | -41.5% | 4,784 | +27.0% | 0.00% | -60.0% |
| Q1 2018 | $400,000 | +82.6% | 3,766 | +2.7% | 0.01% | +66.7% |
| Q4 2017 | $219,000 | – | 3,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |